Speciality Medicines
BSE SME₹2,48,000 / Individual : 2,000 Shares
Speciality Medicines IPO Details
The Speciality Medicines IPO price band is set between ₹117-124 per equity share, with a face value of ₹10 per share. The issue is managed by Skyline Financial Services Pvt.Ltd., and the equity shares are proposed to be listed on the BSE SME.
The IPO date for subscription opens on 20 Mar, 2026 and closes on 24 Mar, 2026. Investors can check the allotment status on 25 Mar, 2026, while the listing date is tentatively scheduled for 30 Mar, 2026.
The total issue size is 23,50,000 shares, aggregating up to ₹29.14 crore. Stay tuned for the latest Speciality Medicines IPO review and GMP updates.
Speciality Medicines IPO Review, Rating & Analysis
Speciality Medicines IPO Review
NO REVIEWSpeciality Medicines IPO Rating
Speciality Medicines IPO Highlights
IPO Date
Mar 20, 2026 - Mar 24, 2026
Listing Date
30 Mar, 2026
Face Value
₹10 Per Equity Share
Price Band
₹117-124 per equity share
Lot Size
-
Fresh Issue
Shares
Offer for Sale
-
Listing At
BSE SME
Speciality Medicines IPO Lot Size
The minimum market lot for Speciality Medicines IPO is 2 shares with an application amount of ₹248. Retail investors can apply for up to 806 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2 | ₹248 |
| Retail (Max) | 806 | 1612 | ₹1,99,888 |
| S-HNI (Min) | 807 | 1614 | ₹2,00,136 |
| S-HNI (Max) | 4032 | 8064 | ₹9,99,936 |
| B-HNI (Min) | 4033 | 8066 | ₹10,00,184 |
Speciality Medicines IPO Timeline
Issue Price
₹117-124 per equity shareFace Value
₹10 Per Equity ShareListing at Group
BSE SMERegistrar
Skyline Financial Services Pvt.Ltd.Lead Manager
UNISTONE CAPITAL PRIVATE LIMITEDIssue Size
23,50,000 shares(aggregating up to ₹29.14 crore)Speciality Medicines IPO Documents
Speciality Medicines IPO Valuations
EPS Pre IPO
₹/-EPS Post IPO
₹/-PE Pre IPO
-PE Post IPO
-ROE
-ROCE
-Debt Equity
-RoNW
-PAT Margin
-Price to Book Value
-Promoters & Share Holding
Promoter(s) Name
- Parth B Goyani
- Goyani Sumit Babubhai
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 59.28% | 43.44% |
About Company
Incorporated in the year 2021, Speciality Medicines Limited is a company involved in the marketing and distribution of finished formulations of speciality medicines across domestic and international markets. The company’s product portfolio includes a wide range of speciality pharmaceutical finished formulations products in various dosage forms, including tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.
The company operates in the following ways: contract manufacturing of finished formulations for international markets and marketing and distribution of sourced specialty pharmaceutical products. The company has expanded to the international market with registered/pending products in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia. The company’s distribution network has established strong relationships with over 20 states in India and over 35 countries worldwide. As of March 31, 2025, the company has 1 product registered overseas and 60 products in the registration process across 5 countries, generating revenue.
As of August 31, 2025, the company had a total of 18 permanent employees in various departments.
Speciality Medicines IPO - Issue Objectives & Utilisation of proceeds
| Objectives | Amount |
|---|---|
| Setting up of Research and Development (R&D) Center | - |
| Product registration in the international markets | - |
| Repayment/ Prepayment, in full or part, of certain borrowings availed by the Company | - |
| To Meet Working Capital Requirements | - |
| General Corporate Purpose | - |
Company Contact Details
Speciality Medicines
913, One World West, S. No. 396, FP 119, Village - Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India - 380051.Phone: +91 22 4604 5344
Email: investors.grievances@specialitymedicine.com
Website: https://specialitymedicine.com
Registrar Contact Details
Skyline Financial Services Private Ltd
Frequently Asked Questions about Speciality Medicines IPO
When will Speciality Medicines IPO open for subscription?
The Speciality Medicines IPO opens on 20 Mar, 2026 and closes on 24 Mar, 2026.
What is the investors portion for Speciality Medicines IPO?
The investors' portion for QIB is N/A%, NII is N/A%, and Retail is N/A%.
How to apply for Speciality Medicines IPO?
You can apply for Speciality Medicines IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Speciality Medicines IPO?
The issue size of Speciality Medicines IPO is approx ₹23,50,000 shares(aggregating up to ₹29.14 crore) crores.
What is the price band of Speciality Medicines IPO?
The price band for Speciality Medicines IPO is ₹117 to ₹124 per equity share.
What is the lot size of Speciality Medicines IPO?
The minimum bid (lot size) for Speciality Medicines IPO is 1000 shares with an investment of approx ₹2,48,000 .
What is the allotment date of Speciality Medicines IPO?
The allotment date for Speciality Medicines IPO is 25 Mar, 2026.
What is the listing date of Speciality Medicines IPO?
The listing date for Speciality Medicines IPO is expected to be 30 Mar, 2026.
What is the GMP of Speciality Medicines IPO?
The latest Grey Market Premium (GMP) for Speciality Medicines IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.
